Iconovo was founded to transform inhaled therapy
The idea for Iconovo arose when Orest Lastow saw a clear need to change and develop the market for inhalation drugs. Many drug developers considered it too difficult and risky to develop inhalation products and abstained for this reason. The generic companies needed a competent partner for the development of generic products to challenge the companies with the original products.
BioStock interviewed Orest Lastow, co-founder and CTO, about Iconovo’s journey from the start to now. Read the full article here